Fastly (FSLY) shares slipped fractionally in premarket trading on Thursday, even as investment firm Piper Sandler upped its ...

Don Schneider, Piper Sandler deputy head of U.S. policy, joins CNBC's 'The Exchange' to discuss portfolio positioning ahead ...

Piper Sandler raised the firm’s price target on ACV Auctions (ACVA) to $18 from $16 and keeps a Neutral rating on the shares following ...

Piper Sandler raised the firm’s price target on Palomar (PLMR) to $110 from $105 and keeps an Overweight rating on the shares after Q3 ...

Fintel reports that on November 7, 2024, Piper Sandler downgraded their outlook for HubSpot (NYSE:HUBS) from Overweight to ...

Celanese (NYSE:CE) -4.7% in Friday's trading to its lowest in more than four years after Piper Sandler downgrades shares to Underweight from Neutral with a $98 price target, slashed from $150, citing ...

"Trump is an unpopular, lame duck president who won a narrow election against a weak opponent and has thin margins in ...

Piper Sandler raises Fastly target to $8; keeps Neutral rating. Fastly's Q3 EPS beats estimates, revenue slightly misses ...

Operator: Good morning. And welcome to the Piper Sandler Companies’ Third Quarter 2024 Earnings Conference Call.

Such findings raised questions about the added benefit of masofaniten, leading ESSA to abandon the drug’s development. In light of these results, Piper Sandler removed any projected value for ...

NEW YORK, Oct. 31, 2024 /PRNewswire/ -- Piper Sandler Companies (NYSE: PIPR), a leading investment bank, and BC Partners Credit, the $8 billion credit arm of international investment firm BC ...

On Tuesday, Piper Sandler began coverage of CAMP4 Therapeutics Corp (NASDAQ:CAMP) stock with an Overweight rating and a price target of $18.00. The firm highlighted CAMP4's innovative work in the ...